Ayvakyt 25 mg
Ayvakyt 25 mg is a medicine authorised by Swissmedic under authorisation number 68294. The authorisation holder is Blueprint Medicines (Switzerland) GmbH. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 06 July 2023 and the authorisation is limited until 05 July 2028. ATC code L01EX18 places the medicine in the group Antineoplastic agents.
| Authorisation number | 68294 |
|---|---|
| Name | Ayvakyt 25 mg |
| Full name | Ayvakyt 25 mg, Filmtabletten |
| Authorisation holder | Blueprint Medicines (Switzerland) GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01EX18 |
| First authorisation | 06 July 2023 |
| Authorisation validity | 05 July 2028 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Ayvakyt 25 mg, Filmtabletten | A | 06 July 2023 |
| 2 | Ayvakyt 50 mg, Filmtabletten | A | 06 July 2023 |
| 3 | Ayvakyt 100 mg, Filmtabletten | A | 06 July 2023 |
| 6 | Ayvakyt 200 mg, Filmtabletten | A | 06 July 2023 |
| 7 | Ayvakyt 300 mg, Filmtabletten | A | 06 July 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Tablette(n) | L01EX18 | 07.16.1. | A |
| 2 | 30 | Tablette(n) | L01EX18 | 07.16.1. | A |
| 3 | 30 | Tablette(n) | L01EX18 | 07.16.1. | A |
| 4 | 30 | Tablette(n) | L01EX18 | 07.16.1. | A |
| 5 | 30 | Tablette(n) | L01EX18 | 07.16.1. | A |
Scroll the table sideways
Frequently asked questions
Is Ayvakyt 25 mg authorised in Switzerland?
Yes. Ayvakyt 25 mg is authorised by Swissmedic under authorisation number 68294, data as of 01 September 2026. The authorisation is limited until 05 July 2028.
Which dispensing category does Ayvakyt 25 mg have?
Ayvakyt 25 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Ayvakyt 25 mg?
The authorisation holder is Blueprint Medicines (Switzerland) GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.